clinical characteristics and malignancy prevalence in idiopathic inflammatory myopathies a single center study from southwestern saudi arabia

Original title: “Clinical Characteristics and Malignancy Prevalence in Idiopathic Inflammatory Myopathies: A Single-Center Study from Southwestern Saudi Arabia.”

serum kl 6 and lung ultrasound b lines a combined non invasive model for screening and predicting interstitial lung disease in idiopathic inflammatory myopathy

Original title: “Serum KL-6 and lung ultrasound B-lines: a combined non-invasive model for screening and predicting interstitial lung disease in idiopathic inflammatory myopathy.”

new hope with car t cell therapy for refractory idiopathic inflammatory myopathies a systematic review

Original title: “A new hope with CAR T-cell therapy for refractory idiopathic inflammatory myopathies: a systematic review.”

risk of second primary cancer and death in patients with idiopathic inflammatory myopathies

Original title: “Risk of second primary cancer and death in patients with idiopathic inflammatory myopathies.”

Conditions: IBM; IIM; Myositis; Inflammatory Myopathy; Dermatomyositis; Dermatomyositis, Juvenile; Anti-synthetase Syndrome; Immune-Mediated Necrotizing Myopathy; Polymyositis; Inclusion Body Myositis; Juvenile Myositis; Juvenile Dermatomyositis Interventions: Other: No intervention - qualitative and mixed methods investigations Sponsors: Myositis International Health & Research Collaborative Alliance Foundation; MIHRA Patient Advisory; Myositis Australia; CureJM; The Myositis Association; The D

Original title: “MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)”